Chemo India Formulation Private Limited - Company Profile

It is a pharma foreign private limited company based in Hyderabad, Telangana, India, established in 2015.
2015 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Chemo India Formulation Private Limited

Chemo India Formulation Private Limited, a active foreign private limited company, was established on 13 August 2015 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U85100TG2015FTC100239. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹130.00 Cr and a paid-up capital of ₹122.36 Cr.

It upholds a compliant status. Employing 225 professional, Its leadership includes Maria Sandra Martin Moran (Director), Satheesh Rao Ponugoti (Company Secretary), Bharat Vasudevan (Director). Past directors included Jaya Gopaldas Ahuja, Bharat Vasudevan, Shubham Girishbhai Barot. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 2B & 2C, Biotech Park, Phase Ii, Lalgadi Malakpet, Hyderabad, Hyderabad, Telangana, 500078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100TG2015FTC100239

  • Registration Number

    100239

  • Incorporation Date

    13 August 2015

  • Authorized Capital

    ₹130.00 Cr

  • Paid-Up Capital

    ₹122.36 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 130.00 Cr
  • Paid Up Capital ₹ 122.36 Cr
  • Company Age 10 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 36.56%
  • Profit Growth **** 19.27%
  • Ebitda **** 54.67%
  • Net Worth 4.96%
  • Total Assets **** 4.27%
Company report

Chemo India Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Chemo India Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Chemo India Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Maria Sandra Martin Moran Director 13 Aug 2015 Current
Satheesh Rao Ponugoti Company Secretary 01 Oct 2023 Current
Bharat Vasudevan Director 06 Jun 2019 Current
Manuel Ignacio Barro Director 06 Jun 2019 Current
Ramachandra Kumar Kurumaddali Managing Director 13 Aug 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Managing Director 27 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Chemo India Formulation.

Chemo India Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.56% increase. The company also saw a substantial improvement in profitability, with a 19.27% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.

Chemo India Formulation revenue growth over time
Chemo India Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 36.56%
*******
*******
*******
*******
Revenue from Operations
*******
 37.06%
*******
*******
*******
*******
Total Assets
*******
 4.27%
*******
*******
*******
*******
Profit or Loss
*******
 19.27%
*******
*******
*******
*******
Net Worth
*******
 4.96%
*******
*******
*******
*******
EBITDA
*******
 54.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Chemo India Formulation?

In 2022, Chemo India Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Chemo India Formulation?

Chemo India Formulation has a workforce of 225 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Chemo India Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemo India Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Chemo India Formulation
Recent Activity within the Organization
  • Annual General Meeting

    Chemo India Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Chemo India Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Satheesh Rao Ponugoti was appointed as a Company Secretary was appointed as a Company Secretary on 01 Oct 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • Director Appointment

    Bharat Vasudevan was appointed as a Director was appointed as a Director on 06 Jun 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • Director Appointment

    Manuel Ignacio Barro was appointed as a Director was appointed as a Director on 06 Jun 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Maria Sandra Martin Moran was appointed as a Director was appointed as a Director on 13 Aug 2015 & has been associated with this company since 10 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Chemo India Formulation Private Limited?

The CIN of Chemo India Formulation Private Limited is U85100TG2015FTC100239.

Where is Chemo India Formulation Private Limited headquartered?

Chemo India Formulation Private Limited is headquartered at Plot No. 2B & 2C, Biotech Park, Phase Ii, Lalgadi Malakpet, Hyderabad, Hyderabad, Telangana, 500078.

When was Chemo India Formulation Private Limited incorporated?

Chemo India Formulation Private Limited was incorporated on 13 August 2015.

Who are the current directors of Chemo India Formulation Private Limited?

The current directors of Chemo India Formulation Private Limited are

What is the primary industry of Chemo India Formulation Private Limited?

The primary industry of Chemo India Formulation Private Limited is Professional, Scientific And Technical.

Is Chemo India Formulation Private Limited a listed company?

Chemo India Formulation Private Limited is unlisted.

What is the capital structure of Chemo India Formulation Private Limited?

The authorized capital of Chemo India Formulation Private Limited is ₹130.00 Cr, and the paid-up capital is ₹122.36 Cr.

What is the compliance status of Chemo India Formulation Private Limited?

The compliance status of Chemo India Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available